Ligand Pharmaceuticals, Inc. (LGND)
188.90
-0.17
(-0.09%)
USD |
NASDAQ |
Jan 02, 15:20
Ligand Pharmaceuticals Research and Development Expense (TTM): 82.10M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Merck & Co., Inc. | 14.26B |
| Johnson & Johnson | 15.77B |
| Inspire Medical Systems, Inc. | 108.56M |
| Elanco Animal Health, Inc. | 356.00M |
| Alnylam Pharmaceuticals, Inc. | 1.248B |